ALAMEDA, Calif., March 8, 2007 (PRIME NEWSWIRE) (PRIMEZONE) -- Avigen, Inc. (Nasdaq:AVGN) a biopharmaceutical company developing innovative therapies for the treatment of chronic neurological conditions, announced today that Michael Coffee, Chief Business Officer, will present information on Avigen's 2007 development programs and product pipeline at Cowen and Company's 27th Annual Health Care Conference on Thursday, March 15, 2007, from 9:30 to 10:05 a.m. ET at the Boston Marriott, Copley Place.
